Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Mar 7, 2013 (14 years ago)

Nupercainal

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Affected NDCs 0067-5812-86 0067-5812-96

Compare with the code on your package — it is the most precise check available.

Drug: Dibucaine

Recalling firm
Novartis Consumer Health
NDC code
0067-5812-96
Origin
NE, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-208-2013 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Dibucaine recalls

See all

Other recalls by Novartis Consumer Health

All 2013 recalls
Class III · Low risk

Loratadine

Failed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.

Terminated Failed specification Novartis Consumer Health D-022-2014